- Home
- FENC vs ENX Comparison
FENC vs ENX Comparison
Compare FENC & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- ENX
- Stock Information
- Founded
- FENC 1996
- ENX 2002
- Country
- FENC United States
- ENX United States
- Employees
- FENC N/A
- ENX N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- ENX Finance/Investors Services
- Sector
- FENC Health Care
- ENX Finance
- Exchange
- FENC Nasdaq
- ENX Nasdaq
- Market Cap
- FENC 172.8M
- ENX 175.5M
- IPO Year
- FENC 2001
- ENX N/A
- Fundamental
- Price
- FENC $6.07
- ENX $9.69
- Analyst Decision
- FENC Strong Buy
- ENX
- Analyst Count
- FENC 2
- ENX 0
- Target Price
- FENC $14.00
- ENX N/A
- AVG Volume (30 Days)
- FENC 173.1K
- ENX 25.4K
- Earning Date
- FENC 11-07-2024
- ENX 01-01-0001
- Dividend Yield
- FENC N/A
- ENX 3.94%
- EPS Growth
- FENC N/A
- ENX N/A
- EPS
- FENC N/A
- ENX 0.16
- Revenue
- FENC $49,348,000.00
- ENX N/A
- Revenue This Year
- FENC $97.94
- ENX N/A
- Revenue Next Year
- FENC $11.50
- ENX N/A
- P/E Ratio
- FENC N/A
- ENX $61.00
- Revenue Growth
- FENC 278.09
- ENX N/A
- 52 Week Low
- FENC $3.96
- ENX $7.84
- 52 Week High
- FENC $11.92
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- FENC 61.50
- ENX 40.16
- Support Level
- FENC $5.77
- ENX $9.90
- Resistance Level
- FENC $6.35
- ENX $9.98
- Average True Range (ATR)
- FENC 0.39
- ENX 0.09
- MACD
- FENC -0.02
- ENX -0.03
- Stochastic Oscillator
- FENC 51.62
- ENX 13.51
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.